Asthma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Gene expression data demonstrate that ABC transporters are variably expressed in epithelial cells from different airway generations, regulated by cigarette smoke exposure (ABCA13, ABCB6, ABCC1, and ABCC3), and differentially expressed in individuals with COPD and asthma (ABCA13, ABCC1, ABCC2, ABCC9).
|
30655622 |
2019 |
Autism Spectrum Disorders
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Mutations in ATP binding cassette subfamily A member 13 (ABCA13) have been recently identified in a monkey that displays behavior associated with ASD.
|
29092799 |
2018 |
Autism Spectrum Disorders
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
The neuropathological investigation of the brain in a monkey model of autism spectrum disorder with ABCA13 deletion.
|
30201574 |
2018 |
Autistic Disorder
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Using this monkey model of autism with an ABCA13 deletion and a mutation of 5HT2c, we neuropathologically investigated the changes in the neuronal formation in the frontal cortex.
|
30201574 |
2018 |
Glioblastoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Further prospective studies are warranted to investigate whether ABCA13 expression can be used to further personalize treatments for GBM.
|
29520610 |
2018 |
Tracheal Diseases
|
0.010 |
AlteredExpression
|
group |
BEFREE |
ABCA13, a member of the ABCA family of proteins, is predicted to transport lipid molecules and is expressed in the human trachea, testis, bone marrow, hippocampus, cortex, and other tissues.
|
29092799 |
2018 |
Pervasive Development Disorder
|
0.010 |
GeneticVariation
|
group |
BEFREE |
The neuropathological investigation of the brain in a monkey model of autism spectrum disorder with ABCA13 deletion.
|
30201574 |
2018 |
Glioblastoma Multiforme
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Further prospective studies are warranted to investigate whether ABCA13 expression can be used to further personalize treatments for GBM.
|
29520610 |
2018 |
Schizophrenia
|
0.420 |
GeneticVariation
|
disease |
BEFREE |
Our results indicate that the ABCA13 gene may contain overlapping common genetic risk factors for both major depressive disorder and schizophrenia in the Han Chinese population.
|
27712136 |
2017 |
Renal Cell Carcinoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Noticeably, elevated expression of ABCA13 and EZH2 is correlated with overall survival of RCC patients, which can be used as potential prognostic markers.
|
28978010 |
2017 |
Mental disorders
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Some research has bridged the variations in ABCA13 with occurrence of psychiatric disorders.
|
27712136 |
2017 |
Unipolar Depression
|
0.010 |
Biomarker
|
disease |
BEFREE |
Our results indicate that the ABCA13 gene may contain overlapping common genetic risk factors for both major depressive disorder and schizophrenia in the Han Chinese population.
|
27712136 |
2017 |
Abnormal behavior
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
Some research has bridged the variations in ABCA13 with occurrence of psychiatric disorders.
|
27712136 |
2017 |
Conventional (Clear Cell) Renal Cell Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Noticeably, elevated expression of ABCA13 and EZH2 is correlated with overall survival of RCC patients, which can be used as potential prognostic markers.
|
28978010 |
2017 |
Major Depressive Disorder
|
0.010 |
Biomarker
|
disease |
BEFREE |
Our results indicate that the ABCA13 gene may contain overlapping common genetic risk factors for both major depressive disorder and schizophrenia in the Han Chinese population.
|
27712136 |
2017 |
Refractory Cytopenia of Childhood
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Noticeably, elevated expression of ABCA13 and EZH2 is correlated with overall survival of RCC patients, which can be used as potential prognostic markers.
|
28978010 |
2017 |
Ovarian Serous Adenocarcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
CIAPIN1 and ABCA13 are markers of poor survival in metastatic ovarian serous carcinoma.
|
25889687 |
2015 |
Renal Cell Carcinoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Genetic aberrations and reduced expression of ERC2 and ABCA13 were frequent in RCCs, and MTOR mutations were identified as one of the major disrupters of cell signaling during renal carcinogenesis.
|
24504440 |
2014 |
Serum albumin measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
A genome-wide assessment of variability in human serum metabolism.
|
23281178 |
2013 |
Colorectal Carcinoma
|
0.300 |
Biomarker
|
disease |
CTD_human |
The role of ABC transporters in progression and clinical outcome of colorectal cancer.
|
22294766 |
2012 |
Colorectal Neoplasms
|
0.300 |
Biomarker
|
group |
CTD_human |
The role of ABC transporters in progression and clinical outcome of colorectal cancer.
|
22294766 |
2012 |
Disease Exacerbation
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
The role of ABC transporters in progression and clinical outcome of colorectal cancer.
|
22294766 |
2012 |
nervous system disorder
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Here, we examined the effects of neurological disorder-related SNPs ABCA13, T4031A and R4843C in the context of ABCA1, and found that the former SNP (T1088A in ABCA1) severely impaired the ABCA1 functions of apolipoprotein A-I (apoA-I) binding and cholesterol efflux.
|
23221702 |
2012 |
Schizophrenia
|
0.420 |
GeneticVariation
|
disease |
BEFREE |
After the initial discovery of its disruption by a chromosome abnormality in a person with schizophrenia, we resequenced ABCA13 exons in 100 cases with schizophrenia and 100 controls.
|
19944402 |
2009 |
Schizophrenia
|
0.420 |
Biomarker
|
disease |
PSYGENET |
After the initial discovery of its disruption by a chromosome abnormality in a person with schizophrenia, we resequenced ABCA13 exons in 100 cases with schizophrenia and 100 controls.
|
19944402 |
2009 |